Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B

This study has been completed.
Novartis Pharmaceuticals
Information provided by:
Novartis Identifier:
First received: August 18, 2005
Last updated: May 8, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)